PTC Expands Rare Disease Portfolio
PTC acquires BLA-stage ST-920 Fabry disease program
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
PTC acquires BLA-stage ST-920 Fabry disease program
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.